Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 7, 2009, Pages 2030-2034

  Li, Christopher I ^a   Mathes, Robert W ^a   Malone, Kathleen E ^a   Daling, Janet R ^a   Bernstein, Leslie ^b   Marchbanks, Polly A ^d   Strom, Brian L ^e   Simon, Michael S ^f   Press, Michael F ^c   Deapen, Dennis ^c   Burkman, Ronald T ^g   Folger, Suzanne G ^d   McDonald, Jill A ^d   Spirtas, Robert ^h  

^a Fred Hutchinson Cancer Research Center   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g BAYSTATE MEDICAL CENTER   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CONTRACEPTIVE AGENT; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIGRAINE; POSTMENOPAUSE; PREMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; STRUCTURED INTERVIEW; UNITED STATES;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; UNITED STATES;

EID: 67650429969     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0291     Document Type: Article

References (19)

1. Mathes RW, Malone KE, Daling JR, et al. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:3116-22.
2. Key T, Appleby P, Barnes I, Reeves G, Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
3. Collaborative Groupon Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
4. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
5. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993;43:S6-10.
6. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-9.
7. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993;33:385-9.
8. Dzoljic E, Sipetic S, Vlajinac H, et al. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002;42:185-93.
9. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000;20:701-7.
10. Kornstein SG, Parker AJ. Menstrual migraines: etiology, treatment, and relationship to premenstrual syndrome. Curr Opin Obstet Gynecol 1997;9:154-9.
11. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95:261-6.
12. Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23:197-205.
13. Marchbanks PA, McDonald JA, Wilson HG, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 2002;12:213-21.
14. Breslow NE, Day NE. Statistical methods in cancer research: Volume I - The analysis of case-control studies. Lyon: International Agency for Cancer Research; 1980. p.5-338.
15. Begg CB, Gray R. Calculation of polychotomous logistic regression parameters using individualized regressions. Biometrika 1984;71:11-8.
16. Collaborative Groupon Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 woemn with breast cancer and 95,067 women without the disease. Br J Cancer 2002;87:1234-45.
17. Takkouche B, Regueira-Mendez C, Etminan M. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 2008;100:1439-47.
18. Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med 1992;152:1273-8.
19. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998;38:87-96.